EZZ Life Science Holdings Ltd (ezz) Logo

EZZ Life Science Holdings Ltd (EZZ)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

EZZ Chart

Snapshot

EZZ's Principal Activity is the formulation, production, marketing and sale of the EZZ branded health supplements to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -37.41%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,343 of 2,418
Sector Rank 204 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies 1ST / MGZ / ANR
EPS $0.06
DPS $0.0045
Book Value Per Share $0.24

Broker Consensus

EZZ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

EZZ Life Science Holdings Limited (EZZ) is engaged in formulation, production, marketing and sale of the EZZ branded health supplements to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Silverwater NSW 2128
Website www.ezzlife.com.au
Registry BoardRoom
Auditor Rothsay Audit & Assurance Pty Ltd
Date Listed 3 Mar 2021

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Prelim)
29/09/2022 Report (Prelim)
27/10/2022 Report (Annual)
27/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
09/11/2021 $0.0045 100% $0.0064 Final 16/12/2021

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.0045
Gross DPS(TTM) $0.0064
Dividend yield
Gross yield
Payout Ratio 8%
DRP No
DRP Features -

Directors & Management

Directors & Management

Name Title Since Bio
Mr Glenn Walter Cross Non-Executive Chairman,Non-Executive Director Dec 2021

Mr Glenn Walter Cross

Non-Executive Chairman,Non-Executive Director

Mr Cross has over 40 years of experience in the life science sector domestically and internationally, including over 20 years in a senior executive capacity. He was formerly Chief Executive Officer and Chief Operation Officer of AusBiotech Ltd for over 13 years. He also managed the Biotech program for the Victorian State Government.

Mr Ivan Oshry Non-Executive Director Oct 2020

Mr Ivan Oshry

Non-Executive Director

Mr Oshry has more than 30 years of experience of legal practice in Australia and internationally, in commercial and corporate law. Mr Oshry was formerly a senior partner at Fluxmans Attorneys in Johannesburg and headed up the corporate department at Kemp Strang (which has since merged with Thomson Geer) in Sydney. He is Chair of the Risk management committee and a member of the Human Resources committee.

Ms Lily (Hao) Huang Non-Executive Director Oct 2020

Ms Lily (Hao) Huang

Non-Executive Director

Ms Huang has over 20 years of experience in the wealth management and banking industry. She has been working with Citi Group Australia since 2017 as Vice President of the APAC Desk of the Investment Partnerships Division. She is chair of the Human resources committee and a member of the Risk committee.

Mr Mark (Qizhou) Qin Chief Operating Officer,Executive Director,Interim Chief Executive Officer Sep 2018

Mr Mark (Qizhou) Qin

Chief Operating Officer,Executive Director,Interim Chief Executive Officer

Mr Qin has a background in management consulting and experience in sales and marketing. Prior to co-founding the Company in 2018, he co-founded marketing consulting firm, CE International. Mr Qin also authored five books in sales and marketing for the consumer health industry between 2003 and 2008.

Ms Natalie Sylvia Climo Company Secretary N/A
Anthony Guarna Chief Financial Officer N/A

Director Transactions

EZZ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
19/05/21 Luis Rodriguez-Bravo Buy +3,600 $0.52 $1,872 On-market trade
15/03/21 Luis Rodriguez-Bravo Sell +20,000 $0.83 ($16,600) On-market trade

Director Interests

The current holdings of EZZ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Glenn Cross 01/12/2021 0 N/A N/A N/A
Mark (Qizhou) Qin 30/06/2021 N/A 11,344,000 N/A N/A
Ivan Oshry 30/06/2021 10,000 N/A N/A N/A
Lily (Hao) Huang 27/10/2020 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 20, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Macquarie Holdings Pty Ltd 17,016,000 40.51%
JNJ Mok Pty Ltd 11,344,000 27.01%
Yong Cao 1,760,000 4.19%
Zhaoying Wang 480,000 1.14%
Jing Chen 480,000 1.14%
Haitao Zheng 480,000 1.14%
BNP Paribas Nominees Pty Ltd < IB AU Noms Retail Client Drp> 413,536 0.99%
Oren Danziger 285,606 0.68%
Indrawaty Mei Hua Ong 239,038 0.57%
Li Zhu <Knight Holding Fund A/C> 200,000 0.48%
Silvia Fei Cing Jian 200,000 0.48%
Mr William Darrell Mc Innes & Ms Melanie Larraine Cassy <Watt- Mcinnes Super Fund A/C> 200,000 0.48%
Australia Capital Finance Investment Pty Ltd 195,000 0.46%
GE Equity Investments Pty Ltd 190,000 0.45%
Oli Private Investment Pty Ltd 187,312 0.45%
Mr Nicholas Galatis & Mrs Effie Galatis 180,000 0.43%
Mr Ying Chuang Wang 170,793 0.41%
Miss Emma Michelle Sievwright 150,000 0.36%
Mr Maxwell Alan Read & Mrs Mary Ann Read <Quillsville Super Fund A/C> 136,421 0.33%
Mr Paul John Battocchio 125,000 0.30%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 180 312 113 177 22 804

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Macquarie Holdings Pty Ltd 20/09/2021 17,016,000 40.51
JNJ Mok Pty Ltd 20/09/2021 11,344,000 27.01

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.445 30 June
EZZ Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.